Key result
Rosuvastatin is linked to acute reversible erythromelalgia and myopathy in a case report.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
BACKGROUND: Secondary erythromelalgia can occur due to various underlying medical disorders or drug toxicity. MAIN OBSERVATIONS: A 75-year old male developed acute secondary erythromelalgia following the onset of rosuvastatin use and associated myopathy. The illness was reversible after discontinuation of the pharmacological agent. CONCLUSION: Secondary erythromelalgia may occur after rosuvastatin use, but this and other dermatological toxicities are rare.
No takes yet. Share an insight, caveat, or question.
Cimolai et al. (2009) conducted a case report in Secondary erythromelalgia and rosuvastatin-associated myopathy (n=1). Rosuvastatin was evaluated on Reversibility of acute secondary erythromelalgia and myopathy after drug discontinuation. Rosuvastatin use was associated with acute secondary erythromelalgia and myopathy in a 75-year-old male (n=1), which resolved after discontinuing the drug.
Synapse has enriched 10 related papers. Consider them for comparative context: